[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342869-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342869-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploration-and-prognostic-analysis-of-two-types-of-high-risk-ovarian-cancers-clear-cell-vs-serous-carcinoma-a-population-based-study","Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma - a population-based study","","Ovarian clear cell carcinoma (OCCC) is rare and has substantially lower survival in advanced stages (Stage III–IV) than advanced serous ovarian cancer (OSC), the most common histotype. This population-based study compares OSC and OCCC to identify high-risk OCCC and potential risk and prognosis markers. Using SEER data (2009–2018), logistic/Cox models, Kaplan–Meier survival analysis, and a Cox nomogram evaluate cancer-specific and overall survival, while immunohistochemistry assesses GPC3 expression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploration-and-prognostic-analysis-of-two-types-of-high-risk-ovarian-cancers-clear-cell-vs-serous-carcinoma-a-population-based-study/342869/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploration-and-prognostic-analysis-of-two-types-of-high-risk-ovarian-cancers-clear-cell-vs-serous-carcinoma-a-population-based-study/342869.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of comparing OSC and OCCC in this study?","Question",{"text":63,"@type":64},"To identify high-risk OCCC by comparing OSC and OCCC and investigating potential risk and prognosis markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data source and patient period were used for the analyses?",{"text":68,"@type":64},"Patients with ovarian cancer from 2009 to 2018 were identified from the SEER Program.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors were identified as prognostic variables for advanced OCCC in the Cox analysis?",{"text":72,"@type":64},"Age (45–65 years), tumor numbers, T3 stage, bilateral tumors, and liver metastases were identified as prognostic variables for advanced OCCC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342869,1790183759,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Liu et al. Journal of Ovarian Research (2024) 17:119 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-024-01435-y](https://doi.org/10.1186/s13048-024-01435-y)  \nRESEARCH Open Access  \nExploration and prognostic analysis of two  types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study  \nTingwei Liu 1†, Yueqing Gao 1†, Shuangdi Li 1* and Shaohua Xu 1*  \nAbstract  \nBackground Ovarian clear cell carcinoma (OCCC) is a rare pathological histotype in ovarian cancer, while the survival rate of advanced OCCC (Stage III-IV) is substantially lower than that of the advanced serous ovarian cancer (OSC), which is the most common histotype. The goal of this study was to identify high-risk OCCC by comparing OSC and OCCC, with investigating potential risk and prognosis markers.  \nMethods Patients diagnosed with ovarian cancer from 2009 to 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER) Program. Logistic and Cox regression models were used to identify risk and prognostic factors in high-risk OCCC patients. Cancer-specific survival (CSS) and overall survival (OS) were assessed using Kaplan-Meier curves. Furthermore, Cox analysis was employed to build a nomogram model. The performance evaluation results were displayed using the C-index, calibration plots, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) . Immunohistochemically approach was used to identify the expression of the novel target (GPC3) .  \nResults In the Cox analysis for advanced OCCC, age (45–65 years), tumor numbers (total number of in situ/malignant tumors for patient), T3-stage, bilateral tumors, and liver metastases could be defined as prognostic variables. Nomogram showed good predictive power and clinical practicality. Compared with OSC, liver metastases had a stronger impact on the prognosis of patients with OCCC. T3-stage, positive distant lymph nodes metastases, and lung metastases were risk factors for developing liver metastases. Chemotherapy was an independent prognostic factor for patient with advanced OCCC, but had no effect on CSS in patients with liver metastases (p = 0 . 0656), while surgery was significantly related with better CSS in these patients (p \u003C 0. 0001) (p = 0 . 0041) . GPC3 expression was detected in all tissue sections, and GPC3 staining was predominantly found in the cytoplasm and membranes.  \nConclusion Advanced OCCC and OCCC with liver metastases are two types of high-risk OCCC. The  \nconstructed nomogram exhibited a satisfactory survival prediction for patients with advanced OCCC. GPC3  \n†Tingwei Liu and Yueqing Gao contributed equally to this work.  \n*Correspondence: Shuangdi Li[lishuangdi21@126.com](lishuangdi21@126.com)[ ](lishuangdi21@126.com)Shaohua Xu [xushaohua@tongji.edu.cn](xushaohua@tongji.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the","cbCairhmEFTUI4lZ","https://ap.wps.com/l/cbCairhmEFTUI4lZ","pdf",3759422,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epithelial ovarian cancer burden and screening limitations\n## OCCC epidemiology and clinical characteristics\n## Relationship with endometriosis and therapy response","[{\"question\":\"What was the main goal of comparing OSC and OCCC in this study?\",\"answer\":\"To identify high-risk OCCC by comparing OSC and OCCC and investigating potential risk and prognosis markers.\"},{\"question\":\"Which data source and patient period were used for the analyses?\",\"answer\":\"Patients with ovarian cancer from 2009 to 2018 were identified from the SEER Program.\"},{\"question\":\"What factors were identified as prognostic variables for advanced OCCC in the Cox analysis?\",\"answer\":\"Age (45–65 years), tumor numbers, T3 stage, bilateral tumors, and liver metastases were identified as prognostic variables for advanced OCCC.\"}]","Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma - a population-based study | PDF",1790048491,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4dda14788d3e5e2048255693928d128.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/516e5aa0aad414cbf0a85e56b8f452ae.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52243b6356d01610421524d091580e10.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9790781c7e3f5b5af250f3afb1458009.webp",980,1306]